MedTrace Logo

Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care

NCT00345657 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2006-06-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the benefits of combination niacin ER/lovastatin in patients receiving standard care who are not at LDL goal per ATP III guidelines.

Conditions

Interventions

DRUG

Niacin Extended Release/Lovastatin

Sponsors & Collaborators

  • Kos Pharmaceuticals

    collaborator INDUSTRY

  • In His Image

    lead OTHER

Principal Investigators

  • Jason A Logan, MD · In His Image Family Medicine Residency

  • Edward Rylander, MD · In His Image Family Medicine Residency

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Completion
2004-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00345657 on ClinicalTrials.gov